DoseMe, a global leader in model-informed precision dosing (MIPD) software and a portfolio company of Fairlong Capital, announces the acquisition of Firstline, a leading clinical decision support platform utilized worldwide. Firstline enables clinicians to rapidly access local, evidence-based infectious disease treatment guidance, susceptibility patterns, and antimicrobial stewardship (AMS) resources. The combination of DoseMe and Firstline creates a single, connected experience from therapy selection through personalized dosing, giving clinicians a faster path to optimal care.
Read the full article: DoseMe Acquires Firstline to Build End-to-End Clinical Decision Support for Health Systems in the Global Fight Against Infectious Disease //
Source: https://www.businesswire.com/news/home/20251103817621/en/DoseMe-Acquires-Firstline-to-Build-End-to-End-Clinical-Decision-Support-for-Health-Systems-in-the-Global-Fight-Against-Infectious-Disease